One-Pot and Solvent Free Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ones Using Recyclable Resin Purolite CT275DR as a Heterogeneous Catalyst via Three-Component Biginelli-Like Reactions

References

• M. E. A. Zaki, E. M. Morsy, F. M. Abdel-Motti, and F. M. E. Ab-del Megeid, “Pyrazolopyranopyrimidines as a Class of Anti-Inflammatory Agents,” Heterocyclic Communications 10 (2004): 97–102.
   Web of Science ®Google Scholar
• E. S. Tamany, F. A. Sahed, and B. H. Mohamed, “Synthesis of Some Pyrazolo[3,4-d] Pyrimidines and Their Fused Triazole and Tetrazole Derivatives,” Journal of the Serbian Chemical Society 64 (1999): 9–18.
   Web of Science ®Google Scholar
• S. A. Assiery, G. H. Sayed, and A. Fouda, “Synthesis of Some New Annulated Pyrazolo-Pyrido (or Pyrano) Pyrimidine, Pyrazolopyridine and Pyranopyrazole Derivatives,” Acta Pharmaceutica 54, no. 2 (2004): 143–50.
   PubMedGoogle Scholar
• Zhong-Hua Li, Xue-Qi Liu, Peng-Fei Geng, Feng-Zhi Suo, Jin-Lian Ma, Bin Yu, Tao-Qian Zhao, Zhao-Qing Zhou, Chen-Xi Huang, Yi-Chao Zheng, et al. “Discovery of [1,2,3]Triazolo[4,5-d]Pyrimidine Derivatives as Novel LSD1 Inhibitors,” ACS Medicinal Chemistry Letters 8, no. 4 (2017): 384–89.
   PubMed Web of Science ®Google Scholar
• R. B. Ajmal, S. D. Rajendra, A. N. Gowhar, U. Israr, and A. Tabassum, “Proficient Synthesis of Bioactive Annulated Pyrimidine Derivatives: A Review,” Journal of Taibah University for Science11 (2017): 1047–69. doi:10.1016/j.jtusci.2017.05.005.
   Web of Science ®Google Scholar
• E. Vitaku, D. T. Smith, and J. T. Njardarson, “Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals,” Journal of Medicinal Chemistry 57, no. 24 (2014): 10257–74. doi:10.1021/jm501100b.
   PubMed Web of Science ®Google Scholar
• R. W. Lewis, J. Mabry, J. G. Polisar, K. P. Eagen, B. Ganem, and G. P. Hess, “Dihydropyrimidinone Positive Modulation of Delta-Subunit-Containing Gamma-Aminobutyric Acid Type a Receptors, Including an Epilepsy-Linked Mutant Variant,” Biochemistry 49, no. 23 (2010): 4841–51.
   PubMed Web of Science ®Google Scholar
• X. Zhu, G. Zhao, X. Zhou, X. Xu, G. Xia, Z. Zheng, L. Wang, X. Yang, and S. Li, “2,4-Diaryl-4,6,7,8-Tetrahydroquinazolin-5(1H)-One Derivatives as Anti-HBV Agents Targeting at Capsid Assembly,” Bioorganic & Medicinal Chemistry Letters 20, no. 1 (2010): 299–301.
   PubMed Web of Science ®Google Scholar
• K. L. Dhumaskar, S. N. Meena, S. C. Ghadi, and S. G. Tilve, “Graphite Catalyzed Solvent Free Synthesis of Dihydropyrimidin-2(1H)-Ones/Thiones and Their Antidiabetic Activity,” Bioorganic & Medicinal Chemistry Letters 24, no. 13 (2014): 2897–99.
   PubMed Web of Science ®Google Scholar
• J. S. Pudlo, M. R. Nassiri, E. R. Kern, L. L. Wotring, J. C. Drach, and L. B. Townsend, “Synthesis, Antiproliferative, and Antiviral Activity of Certain 4-Substituted and 4,5-Disubstituted 7-[(1,3-Dihydroxy-2-Propoxy)Methyl]Pyrrolo[2,3-d]Pyrimidines,” Journal of Medicinal Chemistry 33, no. 7 (1990): 1984–92.
   PubMed Web of Science ®Google Scholar
• R. Chikhale, S. Menghani, R. Babu, R. Bansode, G. Bhargavi, N. Karodia, M. V. Rajasekharan, A. Paradkar, and P. Khedekar, “Development of Selective DprE1 Inhibitors: Design, Synthesis, Crystal Structure and Antitubercular Activity of Benzothiazolylpyrimidine-5-Carboxamides,” European Journal of Medicinal Chemistry 96 (2015): 30–46.
   PubMed Web of Science ®Google Scholar
• U. Rashid, R. Sultana, N. Shaheen, S. F. Hassan, F. Yaqoob, M. J. Ahmad, F. Iftikhar, N. Sultana, S. Asghar, M. Yasinzai, et al. “Structure Based Medicinal Chemistry-Driven Strategy to Design Substituted Dihydropyrimidines as Potential Antileishmanial Agents,” European Journal of Medicinal Chemistry 115 (2016): 230–44.
   PubMed Web of Science ®Google Scholar
• Abel Crespo, Abdelaziz El Maatougui, Pierfrancesco Biagini, Jhonny Azuaje, Alberto Coelho, José Brea, María Isabel Loza, María Isabel Cadavid, Xerardo García-Mera, Hugo Gutiérrez-de-Terán, et al. “Discovery of 3,4-Dihydropyrimidin-2(1H)-Ones as a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists,” ACS Medicinal Chemistry Letters 4, no. 11 (2013): 1031–36.
   PubMed Web of Science ®Google Scholar
• J. H. Clark, Ed., Catalysis of Organic Reactions by Supported Reagents (New York: VCH Publishers, 1994).
   Google Scholar
• R. A. Sheldon and H. Van Bekkum, Catalysis through Heterogeneous Catalysis (Weinheim: Wiley-VCH, 2002).
   Google Scholar
• Rajendra V. Patil, Jagdish U. Chavan, Dipak S. Dalal, Vaishali S. Shinde, and Anil G. Beldar, “Biginelli Reaction: Polymer Supported Catalytic Approaches,” ACS Combinatorial Science 21, no. 3 (2019): 105–48.
   PubMed Web of Science ®Google Scholar
• A. Chakrabarti and M. M. Sharma, “Cationic Ion Exchange Resins as Catalyst,” Reactive Polymers 20, no. 1–2 (1993): 1–45.
   Google Scholar
• M. Kuzminska, R. Backov, and E. M. Gaigneaux, “Behavior of Cation-Exchange Resins Employed as Heterogeneous Catalysts for Esterification of Oleic Acid with Trimethylolpropane,” Applied Catalysis A: General 504 (2015): 11–6. doi:10.1016/j.apcata.2014.12.043.
   Web of Science ®Google Scholar
• D. C. Boffito, C. Pirola, F. Galli, A. D. Michele, and C. L. Bianchi, “Free Fatty Acids Esterification of Waste Cooking Oil and Its Mixtures with Rapeseed Oil and Diesel,” Fuel 108 (2013): 612–19.
   Web of Science ®Google Scholar
• J.-Y. Park, D.-K. Kim, and J.-S. Lee, “Esterification of Free Fatty Acids Using Water-Tolerable Amberlyst as a Heterogeneous Catalyst,” Bioresource Technology 101, no. Suppl 1 (2010): S62–S65.
   PubMed Web of Science ®Google Scholar
• Benjamín Torres Olea, Inmaculada Fúñez Nuñez, Cristina García. Sancho, Juan Antonio. Cecilia, Ramón Moreno Tost, and Pedro Maireles. Torres, “Production of Biofuels by 5-Hydroxymethylfurfural Etherification Using Ion-Exchange Resins as Solid Acid Catalysts,” Chemistry Proceedings 2 (2020): 34.
   Google Scholar
• Jesús Esteban, Félix García-Ochoa, and Miguel Ladero, “Solventless Synthesis of Solketal with Commercially Available Sulfonic Acid Based ion Exchange Resins and Their Catalytic Performance,” Green Processing and Synthesis 6 (2017): 79–89.
   Google Scholar
• Mahmood Kamali, Abbas Shockravi, Maryam Saghafi Doost, and Seyyed Emad Hooshmand, “One-Pot, Solvent-Free Synthesis via Biginelli Reaction: Catalyst-Free and New Recyclable Catalysts,” Cogent Chemistry 1, no. 1 (2015): 1081667.
   Web of Science ®Google Scholar
• E. Abbaspour-Gilandeh, S. C. Azimi, and A. Mohammadi-Barkchai, “Li(Glycine)(CF3SO3) as an Effective and Recoverable Catalyst for the Preparation of 3,4-Dihydropyrimidine-2-(1H)-One Under Solvent-Free Conditions,” RSC Advances 4, no. 97 (2014): 54854–63.
   Web of Science ®Google Scholar
• Dennis Russowsky, Rômulo F. S. Canto, Sergio A. A. Sanches, Marcelo G. M. D'Oca, Angelo de Fátima, Ronaldo A. Pilli, Luciana K. Kohn, Márcia A. Antônio, and João Ernesto de Carvalho, “Synthesis and Differential Antiproliferative Activity of Biginelli Compounds Against Cancer Cell Lines: Monastrol, Oxo-Monastrol and Oxygenated Analogues,” Bioorganic Chemistry 34, no. 4 (2006): 173–82.
   PubMed Web of Science ®Google Scholar
• Mohammad Bakherad, Mohaddeseh Javanmardi, Raheleh Doosti, and Reza Tayebee, “A Highly Efficient and Green Catalytic Synthesis of 3,4-Dihydro-Pyrimidin-2-(1H)-Ones (Thiones) Using 3-Sulfonic Acid-1-Imidazolopyridinium Hydrogen Sulfate under Solvent-Free Conditions,” Croatica Chemica Acta 90, no. 1 (2017): 53–58.
   Web of Science ®Google Scholar
• A. D. Patil, N. V. Kumar, W. C. Kokke, M. F. Bean, A. J. Freyer, C. D. Brossi, S. Mai, A. Truneh, D. J. Faulkner, B. Carte, et al. “Novel Alkaloids from the Sponge Batzella sp.: Inhibitors of HIV gp120-Human CD4 Binding,” The Journal of Organic Chemistry 60, no. 5 (1995): 1182–88.
   Web of Science ®Google Scholar
• R. Ghosh, S. Maiti, and A. Chakraborty, “In(OTf)3-Catalysed One-Pot Synthesis of 3,4-Dihydropyrimidin-2(lH)-Ones,” Journal of Molecular Catalysis A: Chemical 217, no. 1–2 (2004): 47–50.
   Google Scholar
• Molinspiration, Chemoinformatics Brastislava, Slovak Republic, http://www.molinspiration.com/cgi-bin/properties2014
   Google Scholar
• Drug-likeness and molecular property prediction, http://www.molsoft.com/mprop/
   Google Scholar